Adaptive Biotechnologies Corporation (ADPT) vs Sotera Health Company (SHC)
- Adaptive Biotechnologies Corporation ADPT 27.17 +1.27%
- Sotera Health Company SHC 15.81 −0.38%
Adaptive Biotechnologies Corporation and Sotera Health Company are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation and Sotera Health Company are of similar size ($4.5B and $4.3B). Adaptive Biotechnologies Corporation has negative trailing earnings, so its P/E is not meaningful; Sotera Health Company trades at 26.3×. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 17.9% against 6.90%. Sotera Health Company has the higher net margin (14.1% vs −23.7%) and the higher return on invested capital (9.80% vs 0.00%). Across the 18 metrics below, Sotera Health Company leads on 13 and Adaptive Biotechnologies Corporation on 5.
Valuation
Profitability
| Metric | ADPT | SHC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 54.62% | 48.32% |
| Operating margin | (16.18%) | 32.66% | (5.68%) |
| Net margin | (23.66%) | 14.11% | (4.10%) |
| Free cash flow margin | (2.96%) | 11.01% | 0.00% |
| Return on equity | (36.34%) | 27.03% | 0.00% |
| Return on assets | (12.02%) | 5.28% | (6.05%) |
| Return on invested capital | 0.00% | 9.80% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack